Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2025-12-24 @ 10:57 PM
Study NCT ID:
NCT06848569
Status:
RECRUITING
Last Update Posted:
2025-02-27
First Post:
2025-02-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: A Phase II Study
Sponsor:
Sun Yat-sen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-10-23
Start Date Type:
ACTUAL
Primary Completion Date:
2027-10-23
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-10-23
Completion Date Type:
ESTIMATED
First Submit Date:
2025-02-07
First Submit QC Date:
None
Study First Post Date:
2025-02-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-26
Last Update Post Date:
2025-02-27
Last Update Post Date Type:
ACTUAL